LFCR
NASD Lifecore Biomedical, Inc.$6.56 ↑ +0.04 (+0.54%) Trading Up from the previous close of $6.52, $0.01 below the day’s high of $6.57
- YTD change
- -19.87%
- vs 20-day SMA
- +47.63%
- vs 200-day SMA
- +15.20%
Price ranges
Price & Performance
+2.73 (+72.03%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 42.8% away from all-time highs of $11.46
- LFCR is down 20% since the beginning of the year
- LFCR is down 8% over the past 12 months
- LFCR is up 44% over the past 1 month
- 7% of all LFCR investors are betting against LFCR
LFCR reads very good: price sits above both the 20- and 200-day averages, the 12-month move is -8.8%.
- Previous minute
- +$0.00
- Last hour
- +$0.02
- Last 5 days
- +46.32%
- vs 8-day SMA
- +40.57%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. It focuses on selling products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic and other markets. The company was founded by Otto Sartorius in 1965 and is headquartered in Chaska, MN.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
